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INTRODUCTION
Arteries form highly branched networks that ramify throughout the
body. Most arteries branch into progressively smaller diameter
arterioles that in turn branch into even smaller sized capillaries,
which supply oxygen and nutrients to tissues and organs. However,
some arterioles directly connect with other arterioles, usually from
a neighboring arterial tree, and form so-called native collateral
arteries (Chalothorn and Faber, 2010). The native collateral
circulation represents a major conduit for blood supply to tissues
after occlusion of one of the feed arteries. Increases in shear stress
and activation of inflammatory pathways upon occlusion trigger the
outward remodeling of these pre-existing bypasses (Arras et al.,
1998; Eitenmüller et al., 2006). Their presence minimizes tissue
injury after ischemia caused by atherosclerotic, atherothrombotic
and thromboembolic vaso-occlusive disease, which are the major
causes of morbidity and mortality in developed countries.
In addition to the extent of the native collateral circulation, tissue
perfusion following an ischemic insult is enhanced by
arteriogenesis, which can occur by enlargement of native collaterals
or by de novo formation of arterioles, and by angiogenesis: the
sprouting of new capillaries (Carmeliet, 2000). Numerous clinical
attempts to increase angiogenesis in individuals with ischemic
disease by administration of growth factors have failed (Grundmann
et al., 2007), leading to the increased recognition that strategies to
improve tissue perfusion need to focus on improving the extent of
the collateral circulation and arteriogenesis (Schaper, 2009). Despite
the clinical importance, factors influencing arterial branching
morphogenesis and collateral network formation remain poorly
characterized.
Here, we examined whether Delta-like 4 (Dll4)-Notch signaling,
a pathway previously implicated in the regulation of arterial identity
and angiogenic sprouting (Phng and Gerhardt, 2009; Swift and
Weinstein, 2009) determines arteriogenesis and collateral vessel
formation. Dll4 is a transmembrane ligand of Notch receptors that
is selectively expressed in arterial endothelial cells and angiogenic
tip cells during development (Benedito et al., 2009; Hellström et
al., 2007; Shutter et al., 2000; Suchting et al., 2007). Dll4−/− mutant
mice show reduced aorta size and ectopic expression of venous
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SUMMARY
Arteriogenesis requires growth of pre-existing arteriolar collateral networks and determines clinical outcome in arterial occlusive
diseases. Factors responsible for the development of arteriolar collateral networks are poorly understood. The Notch ligand Delta-
like 4 (Dll4) promotes arterial differentiation and restricts vessel branching. We hypothesized that Dll4 may act as a genetic
determinant of collateral arterial networks and functional recovery in stroke and hind limb ischemia models in mice. Genetic loss-
and gain-of-function approaches in mice showed that Dll4-Notch signaling restricts pial collateral artery formation by modulating
arterial branching morphogenesis during embryogenesis. Adult Dll4+/− mice showed increased pial collateral numbers, but stroke
volume upon middle cerebral artery occlusion was not reduced compared with wild-type littermates. Likewise, Dll4+/− mice showed
reduced blood flow conductance after femoral artery occlusion, and, despite markedly increased angiogenesis, tissue ischemia was
more severe. In peripheral arteries, loss of Dll4 adversely affected excitation-contraction coupling in arterial smooth muscle in response
to vasopressor agents and arterial vessel wall adaption in response to increases in blood flow, collectively contributing to reduced flow
reserve. We conclude that Dll4-Notch signaling modulates native collateral formation by acting on vascular branching morphogenesis
during embryogenesis. Dll4 furthermore affects tissue perfusion by acting on arterial function and structure. Loss of Dll4 stimulates
collateral formation and angiogenesis, but in the context of ischemic diseases such beneficial effects are overruled by adverse
functional changes, demonstrating that ischemic recovery is not solely determined by collateral number but rather by vessel
functionality.
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markers in the aorta, consistent with impaired arterial specification
(Duarte et al., 2004; Gale et al., 2004). Conditional overexpression
of Dll4 results in an enlarged aorta, and reduced vascular branching
during embryogenesis (Trindade et al., 2008). Dll4 acts as a
repressor of endothelial tip cell formation and loss of Dll4 stimulates
excessive tip cell formation resulting in hyperbranching of retinal
vessels (Hellström et al., 2007; Suchting et al., 2007). The Dll4-
Notch pathway regulates VEGF receptor expression in sprouting
vessels and decreases VEGF responsiveness (Phng and Gerhardt,
2009). VEGF is a potent pro-angiogenic factor in ischemic
conditions, and is thought to be a determinant of adult arteriogenesis
in mice (Clayton et al., 2008). The cellular mechanism is believed
to involve sprouting angiogenesis (Lucitti et al., 2012). Acute
blockade of Notch signaling using an extracellular Dll4 decoy
increases sprouting of ischemic capillaries following femoral artery
ligation in mice (Al Haj Zen et al., 2010), indicating that Dll4-Notch
signaling restricts post-ischemic angiogenesis. Likewise, Notch
signaling blockade leads to hypersprouting of tumor vessels and
decreases tumor growth because of failure to form a functional
vascular network (Thurston et al., 2007).
In addition to negative effects on sprouting, Notch signaling has
also been shown to have effects on vessel remodeling. Inhibition of
Notch signaling prevented vessel regression in normal retinal
development and in the oxygen-induced retinopathy model in mice
(Lobov et al., 2011). Dll4/Notch inhibition increased the expression
of vasodilators adrenomedullin and suppressed the expression of
the vasoconstrictor angiotensinogen (a precursor of angiotensin II)
in a VEGF-independent manner. Angiotensin II was shown to
induce vasoconstriction and induced vessel regression, whereas
angiotensin inhibitors inhibited vessel regression (Lobov et al.,
2011). These observations suggested that Dll4-Notch inhibition
might have beneficial effects on post-ischemic arteriogenesis by
regulating vascular tone and preventing vessel regression. Finally,
possible effects of Dll4-Notch signaling on formation of the
collateral network have not been investigated yet.
Here, we have used genetic loss- and gain-of-function models in
mice to define the role of Dll4 in arteriogenesis. We show that Dll4-
Notch signaling restricts collateral vessel formation by modulating
arterial branching morphogenesis. We furthermore examined the
relationship between collateral network size and functional recovery
of ischemic tissues using stroke and hind limb ischemia models.
Our results show that despite increased collateral vessel numbers,
Dll4+/− mice show poor blood flow recovery upon arterial
occlusion. These results suggest that improved clinical and
functional outcome after arterial occlusion do not simply rely on




Dll4+/− heterozygous mice have been described previously (Duarte et al.,
2004) and collateral vessel density was assessed by X-gal staining and after
backcrossing onto Gja5+/eGFP mice (Miquerol et al., 2004). Both Dll4+/−
and Gja5+/eGFP strains were maintained on a CD1 background. Cdh5-
Cre:Notch1flox/flox mice and conditional mDll4 gain-of-function mice have
been described previously (Feil et al., 1996; Feil et al., 1997; Hellström et
al., 2007; Deutsch et al., 2008; Trindade et al., 2008). Transgene expression
induction was achieved by administration of doxycycline at 2 mg/ml in
drinking water to the mothers from P0 up to P9. Mice were genotyped by
PCR, assessing tail GFP and β-galactosidase staining. Whole-mount lacZ
stainings were performed as described previously (Suchting et al., 2007).
Animal experiments were carried out in accordance with European
Community standards on the care and use of laboratory animals, with
German Law for the protection of animals and with National Institute of
Health guidelines for care and use of laboratory animals; the protocols were
approved by the local ethical committee.
Inhibition of Notch activation
To evaluate the role of Notch receptor signaling in collateral vessel
formation, pregnant mice were injected intraperitoneally with DAPT
(100 mg/kg body weight) or vehicle (5% ethanol/corn oil) at embryonic day
E10.5, E11.5 and E12.5. Embryos were collected and analyzed at E13.5.
Furthermore, newborn mice received either DAPT (100 mg/kg body
weight) or vehicle subcutaneously at postnatal day P2 and P4. Neonatal
pups were culled at day P5 and P9, and pial collateral circulation was
analyzed. Pregnant Cdh5-Cre:Notch1flox/flox female mice were injected with
tamoxifen (1 mg/kg body weight) at E11.5 and embryos were analyzed at
E13.5.
Immunohistochemistry
For whole-mount staining, dissected tissues/embryos were fixed in 4%
paraformaldehyde for 2 hours on ice and blocked overnight in blocking
buffer [PBS/0.5% blocking reagent (Perkin)/0.3% Triton X-100/0.2%
BSA]. Tissues/embryos were incubated overnight at 4°C with primary
antibodies in blocking buffer (Cy3-conjugated anti-SMA, Sigma, 1:500)
and anti-collagen IV (Novotec, 1:100). Tissues/embryos were washed in
PBS/0.3% TX-100 and incubated overnight with species-specific
fluorescent secondary antibodies [Alexa 488 (Invitrogen), 1:200]. The
samples were then washed in PBS/0.3% TX-100 and mounted (Dako
Fluorescent Mounting Medium, Dako). To determine vessel density on
sections, muscles were excised, fixed with 4% phosphate-buffered
paraformaldehyde, embedded in paraffin and sectioned at 4 μm. Capillaries
were stained with isolectin B4 (1:25; Vector Labs) followed by Alexa Fluor
488 conjugated to streptavidin (1:100; Invitrogen); arteries in wild-type or
Dll4+/− mice backcrossed to arterial reporter Gja5+/eGFP were identified
using an anti-GFP antibody (Abcam). Vessels were imaged using an
Axioskope A1 microscope (Carl Zeiss MicroImaging, Jena, Germany) and
a Coolsnap HQ fluorescent camera (Photometrics) connected to MetaMorph
(Version 7.7.2.0) image analysis software.
RNA and Taqman analysis
Total RNA of femoral artery or gastrocnemius muscle was isolated using the
RNeasy Mini Kit (QIAGEN). A total of 1 µg RNA was used for cDNA
synthesis (Thermoscript First-Strand Synthesis System; Invitrogen). Primers
and probes were ordered from BioTez (Berlin, Germany). Real-time PCR
amplification reaction was performed on a Sequence Detection System
(7900 HT; Applied Biosystems). The comparative CT Method
(DeltaDeltaCT Method) was used to analyze the data and GAPDH was used
as an internal normalization control. The primer sequences and probes are
listed in supplementary material Table S1.
Middle cerebral artery occlusion
The left middle cerebral artery of 8-week-old Dll4+/− or wild-type mice was
occluded as described previously (Nih et al., 2012). Forty-eight hours after
the occlusion, mice were sacrificed and brains were collected. Coronal slices
of forebrain were made using a vibratome (Leica) and were stained with
2% 2,3,5-triphenyltetrazolium chloride (TTC, Sigma). Right and left
hemispheres, and infarction volumes were measured using ImageJ software.
Femoral artery occlusion model, assessment of blood flow with
laser Doppler imaging technique
Occlusion of the right femoral artery in 12-week-old mice was performed
as described previously (Buschmann et al., 2010). For repetitive assessment
of hindlimb blood flow after occlusion, we used the non-invasive laser
Doppler imaging technique (LDF) (Buschmann et al., 2010). The LDF
technique depends on the Doppler principle whereby low-power light from
a monochromatic stable laser (wavelength 830 nm, laser diode, model
LDI2-HR, Moor Instruments, UK), incident on tissue is scattered by moving
red blood cells, photo-detected and processed to provide a blood flow
measurement. The ischemia score was determined as follows: 0, normal; 1,
cyanosis or loss of nail(s); 2, partial or complete atrophy of digit(s); 3, partial
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Arterial blood pressure measurement
Under isoflurane inhalation anesthesia, a catheter (Micro-Renethane
0.25×0.12) was inserted into the abdominal aorta through the left femoral
artery for pressure (BP) measurements. After a 48-hour recovery, BP and
heart rate (HR) were recorded with a transducer (MLT 1050 model)
connected to a computer system for data acquisition and analysis
(PowerLab, ADInstruments) in freely moving unanesthetized animals as
described (Cayla et al., 2007).
MicroCT imaging
For visualization of the arterial collateral network after femoral artery
occlusion, we performed µCT imaging (Zhuang et al., 2006). In short: 7
days after femoral artery occlusion, the abdominal aorta was cannulated and
perfused with 100 mg/kg papaverin hydrochloride (Paveron, Weimer) to
obtain maximal vasodilation, followed by perfusion with contrast agent.
Hindlimb vascular network morphology was imaged and analyzed with a
high resolution µCT imaging system, as described in detail previously
(Zhuang et al., 2006).
Measurement of flow induced remodeling and arteriolar
contractility
To study the effects of chronic changes in blood flow on arteriolar
remodeling, we used the mesenteric ligation model as described previously
(Buschmann et al., 2010; Loufrani et al., 2002). Arterioles of wild type and
Dll4+/− were exposed to high or low blood flow for a period of 7 days and
isolated, and passive diameter-pressure curves were generated using the
arteriograph. Pressure and diameter measurements were collected using a
Biopac data acquisition system (Biopac MP100 and Acknowledge software;
La Jolla, CA, USA).
To examine arteriolar contractility and relaxation behavior, resistance sized
arterioles were isolated and mounted in a wire myograph as described
previously (le Noble et al., 2000). To examine vasoconstriction, arterioles
were challenged with norepinephrine (NE), phenylephrine (Phe) and
angiotensin II (AngII). To examine vasorelaxation response, arterioles were
pre-constricted with 35 mmol/l K+ and challenged with acetylcholine (ACh)
or sodium nitroprusside (SNP). After examination of the arteries in the
myograph, vessels were fixed with 4% PFA under resting tension, isolated
and embedded in paraffin wax. Media thickness was determined on 4 μm
sections stained with Lawson staining solution to visualize the lamina elastica
interna and externa. Plasma leakage in hindlimb muscles was performed using
Evans Blue as described previously (Di Lorenzo et al., 2009).
Statistical analysis
Data are expressed as the mean±s.e.m. P values were calculated (SigmaStat-
Prism Software) using Student’s t-test, Mann-Whitney U test or ANOVA,
as indicated. P<0.05 was considered to be statistically significant.
RESULTS
Dll4 restricts pial collateral artery formation
To examine whether Dll4 affects pial collateral growth, we used
Dll4+/–-deficient CD1 mice carrying a beta-galactosidase reporter
(Duarte et al., 2004) that were intercrossed with transgenic CD1 mice
expressing EGFP driven by the arterial Gja5 (connexin 40) promoter
(Gja5+/eGFP mice) (Miquerol et al., 2004). X-gal staining and EGFP
fluorescence allow detection of arteries and pial arteriolar-arteriolar
collateral anastomoses between the middle cerebral artery (MCA)
and anterior cerebral artery (ACA) (Fig. 1A-D) (Buschmann et al.,
2010). In line with recent studies (Chalothorn and Faber, 2010), we
find that wild-type mice show highest numbers of pial collaterals at
P1, after which their numbers subsequently decrease to reach adult
levels at P21 (Fig. 1A-E). At P1, Dll4+/− mice had about twofold more
pial collateral connections compared with their wild-type littermates
(Fig. 1A-E). Pruning of collaterals during early postnatal stages
proceeded at the same rate in Dll4+/− and in wild type, resulting in
twice as many collaterals in adult Dll4+/− mice (Fig. 1A-E). The
changes in vascular density were independent of brain size as cortex
area was comparable in wild-type and Dll4 heterozygous mice
(Fig. 1F).
As a reduction in Dll4 levels increased brain collateral numbers,
we reasoned that conditional Dll4 overexpression should reduce
Fig. 1. Dll4 modulates pial arteriolar collateral number. 
(A-D) Representative microphotographs of collateral arteriolar
connections (arrows in C,D) between the MCA and the ACA in
wild-type Gja5eGFP/+ (A,C) and Dll4+/− × Gja5eGFP/+ (B,D) brains at
postnatal day 9 (P9). (C,D) Higher magnifications of boxes in
A,B. There are more arterioles in Dll4+/−. Scale bars: 500 μm. 
(E) Collateral arteriolar numbers per hemisphere at different
time points after birth in wild-type and Dll4+/− mice. Collateral
density is highest at time of birth and decreases over time,
indicating that pial collateral connections undergo remodeling
in both wild type and Dll4+/−. Data are shown as mean±s.e.m.,
n=3-5 mice at all time points. ***P<0.001 versus wild type. 
(F) Cortex area quantification at P24 shows no difference
between wild type and Dll4+/−. Values are mean±s.e.m., n=5 or
6 mice per group. (G-J) Representative microphotographs of
collateral connections (arrows in H,J) between MCA and ACA in
wild-type (G,H) and Dll4 gain-of-function (Dll4 GOF; I,J) brains at
P9. Vessels were stained for α-smooth muscle actin (anti-SMA).
Scale bars 500 μm. (K) The number of collateral arterioles
between MCA and ACA in wild-type and Dll4 gain-of-function
brains. Collateral numbers are decreased after Dll4
overexpression. Data are shown as mean±s.e.m., n=13 mice per











native collateral formation. To test this, we used transgenic mice
expressing Dll4 under the control of a tetracycline-inducible
endothelial-specific Tie2 promoter (Trindade et al., 2008).
Transgene expression was induced by administration of
doxycyline in drinking water of the mother in the period between
P0 and P9, and arteriolar collaterals were analyzed by
immunostaining using an antibody directed against α-smooth
muscle actin (αSMA) at P9 (Fig. 1G-J). Isolectin B4
immunostaining of retinal vessels of Dll4 gain-of-function mice
showed a reduction in tip cell numbers, and a reduction in
sprouting angiogenesis, indicating that induction of transgene
expression was successful (supplementary material Fig. S1).
Native collateral connections in brains of Dll4 gain-of-function
mice were significantly reduced in comparison with controls
(P<0.01) (Fig. 1G-K). Taken together, these data show that native
collateral formation in the brain is dependent on the dose of Dll4.
Dll4 and Notch inhibition induce hyperbranching
of embryonic MCA
Evaluation of collateral vessel number showed significant
differences between Dll4+/− and wild type already at the neonatal
stage. Therefore, to establish when the number of collateral vessels
starts to differ between wild type and Dll4+/−, we extended our study
to prenatal stages and analyzed branching morphogenesis of the
MCA by whole-mount immunostaining using the vascular basement
membrane marker collagen IV, of embryonic brains between E11.5
and E15.5 (Fig. 2). In wild-type mice, the MCA formed around
E12.5 and was well developed by E13.5 and E14.5 (Fig. 2A-D,G;
data not shown). MCA formation was slightly delayed in Dll4+/−
mice, and emerged as a clearly defined artery at E14.5. Once
formed, the MCA of both Dll4+/− and wild-type embryos developed
one main branch, and a similar number of second-order arterioles
branching off the main MCA trunk (Fig. 2A-D; supplementary
material Fig. S2). The overall number of distal MCA artery branches
was significantly increased in Dll4+/− compared with wild-type
littermates (Fig. 2G). As the distal branches of the MCA form pial
collateral connections with the ACA (Chalothorn and Faber, 2010),
these data suggest that increased collateral formation in Dll4+/− mice
is a direct consequence of MCA hyperbranching at the level of the
distal parts of the MCA arteriolar tree.
To confirm that the effects of Dll4 on collateral formation are
mediated via Notch receptors, we inhibited Notch signaling using
the γ-secretase inhibitor DAPT. Administration of DAPT
(intraperitoneally, 100 mg/kg body weight) into pregnant mice at
embryonic days E10.5, E11.5 and E12.5 recapitulated distal MCA
hyperbranching, as seen in Dll4+/− embryos (Fig. 2E-G). We next
genetically ablated Notch1 in endothelial cells using tamoxifen-
inducible Cdh5-Cre-ERT2:Notch1flox/flox transgenic mice. Cre
activity was induced by injecting tamoxifen in pregnant mice at
E11.5 (1 mg/kg body weight) and embryos were analyzed at
E13.5. Despite low efficiency of Cre recombination
(supplementary material Fig. S3A,B), distal MCA hyperbranching
was evident in the Cre+ group compared with Cre– controls
(Fig. 2G; supplementary material Fig. S3A,B). We next explored
the possibility that inhibition of Notch signaling during postnatal
stages affects pial collateral numbers. Daily administration of
DAPT during the first 4 postnatal days resulted in a sustained
increase in collateral numbers at later stages (supplementary
material Fig. S3C). Collectively, our data suggest that Dll4
signaling through Notch1 receptors restricts pial collateral
formation by modulating branching morphogenesis of the distal
region of the MCA and the ACA.
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Increased collateral density in Dll4+/− mice or in
mice treated embryonically with DAPT does not
ameliorate post-ischemic recovery after MCA
occlusion
As stroke volume upon MCA occlusion has been shown to correlate
with pial collateral density in mice (Zhang et al., 2010), we reasoned
that heterozygous Dll4+/− animals might be protected from stroke-
induced injury. To test this hypothesis directly, we performed MCA
occlusion and measured stroke volume in Dll4+/− and wild-type
littermates (Fig. 3A,B). Despite increased collateral density in the
pial circulation, stroke volume upon MCA occlusion was not
significantly different between Dll4+/− and wild type at day 2 post-
occlusion (Fig. 3C). Moreover, Dll4+/− brains frequently showed
hemorrhagic lesions (Fig. 3B, blue arrow), which were not observed
in wild-type controls. This suggests additional functional defects in
Dll4+/− pial collaterals.
We next tested whether transient loss of Notch signaling during
embryonic development can augment collateral number and
decrease stroke volume. To achieve this, we treated pregnant mice
Fig. 2. Disruption of the Dll4-Notch1 signaling pathway promotes
embryonic MCA hyperbranching. (A-D) Epifluorescent images of wild-
type and Dll4+/− brains stained for collagen IV at embryonic stages E13.5
(A,B) and E14.5 (C,D). (E,F) Epifluorescent images of collagen IV-stained
brains at embryonic day E13.5 after treatment with DAPT (right panel) or
vehicle (corn oil). MCA in DAPT mice shows increased branching similar
to Dll4+/−. Scale bars: 500 μm. (G) MCA branch point quantification.
Cre–/Cre+: tamoxifen-inducible Cdh5-Cre-ERT2:Notch1flox/flox transgenic
mice. Cre activity was induced by injecting tamoxifen in pregnant mice at
E11.5 (1 mg/kg body weight) and embryos were analyzed at E13.5.












with DAPT at E10.5, E11.5 and E12.5, and let the mice give birth
and grow pups to adulthood. DAPT-treated mice showed an
increased number of collateral vessels compared with vehicle-
treated (corn-oil injected) mice, indicating that it is possible to
increase adult collateral vessel number by transiently interfering
with Notch signaling during embryonic development
(supplementary material Fig. S4A). Mice were then subjected to
middle cerebral artery occlusion. We find that stroke volume was
not significantly different between DAPT-treated and control
animals (supplementary material Fig. S4B). Therefore, both Dll4+/−
mice and mice with transient Notch inhibition induced by treatment
with DAPT during embryogenesis showed increased pial collateral
numbers, but no changes in stroke volume upon MCA occlusion.
Dll4+/− mice show reduced blood flow recovery
upon femoral artery occlusion
To further characterize the role of Dll4 in adaptive vascular
remodeling upon arterial occlusion, we used the mouse hindlimb
ischemia model and examined angiogenesis, arteriogenesis and
functional recovery after occlusion of the femoral artery (FAO).
Functional blood flow recovery was assessed with laser Doppler
flow (LDF) imaging (Fig. 4A,B). Prior to FAO, hindlimb perfusion
was similar between Dll4+/− and wild-type littermates (Fig. 4A,B).
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FAO reduced hindlimb perfusion in Dll4+/− and wild-type mice to
a similar extent, and perfusion remained comparable until day 1
post-FAO (Fig. 4B). However, between day 3 and day 21 post-
occlusion, perfusion recovery was significantly lower (P<0.001) in
Dll4+/− compared with wild type (Fig. 4A,B). As a result, the
ischemia score was significantly higher in Dll4+/− (Fig. 4C).
Angiogenic responses in Dll4+/− hindlimb were more pronounced
compared with wild type, as highlighted by increased capillary
density and capillary to fiber ratios in the ischemic muscle of
Dll4+/− hindlimb (Fig. 4D,E), consistent with previous studies using
acute Notch signaling blockade (Al Haj Zen et al., 2010). Using
Evans blue to detect plasma leakage, we observed increased plasma
leakage in Dll4+/−, especially in the gastrocnemius muscle
(Fig. 4F,G), indicating that the increased angiogenesis in the
ischemic hindlimb of Dll4+/− mice generated immature leaky
vessels.
MicroCT imaging and histological analysis in Dll4+/− and wild-
type unligated control hindlimbs showed comparable arteriolar
densities in both Dll4+/− and wild type (supplementary material
Fig. S5A-C). However, in the occluded ischemic hindlimb we
detected significantly lower arteriolar numbers in Dll4+/− mice
when compared with wild-type littermates (Fig. 5A-C), especially
in Dll4+/− calf muscle (Fig. 5C,D), indicating that, in addition to
defective angiogenesis, arteriogenesis is impaired in Dll4+/− mice.
To rule out that reduced flow recovery was due to altered input
arterial pressure, we measured heart rate and blood pressure in
Dll4+/− and wild-type littermates. Baseline mean arterial blood
pressure (MAP) was slightly elevated in Dll4+/− (supplementary
material Fig. S6A) and heart rates (HR) were comparable with wild
type (supplementary material Fig. S6B). Thus, it is unlikely that a
reduction in arterial pressure accounted for the perfusion deficit in
Dll4+/− mice.
Dll4+/− mice show no defect in arterial
specification
Formation of functional perfused arterial networks requires
specification of arterial identity in vessels (Swift and Weinstein,
2009). To examine possible arterial specification defects, we
analyzed regulators of arterial identity in the ischemic hindlimb.
Expression of Dll4 was, as expected, significantly lower in both the
femoral artery (FA) (P<0.05) and the gastrocnemius muscle
(Gastro) (P<0.01) of Dll4+/− mice (supplementary material
Fig. S7A,B). Both control and ischemic hindlimb expressed Dll4 in
blood vessels (supplementary material Fig. S7C). To test whether
Dll4 haplo-insufficiency impaired the ability to activate the
pathways essential for arterial differentiation, we measured
expression of Hif1a, Hif1b (Arnt – Mouse Genome Informatics),
Vegfa, Kdr, Notch1 (Fig. 6A-E), and the Notch downstream effector
ephrin B2 (Efnb2) at day 7 post-FAO (Fig. 6F). Expression of Efnb2
(Fig. 6F) was significantly upregulated upon FAO in Dll4+/−, and
significantly reduced expression of the other genes was never
observed, thus suggesting that the arterial specification pathway is
functional. As specification signaling appears normal, we next
considered whether changes in arteriolar function might underlie
the observed reduction in perfusion.
Dll4+/− arterioles show altered functional
responses to vasopressor agents and flow
To test for functional changes, we challenged resistance arterioles
from Dll4+/− and wild-type mice with vasoconstrictors and dilators,
and measured force development using the myograph (Fig. 7). The
maximal contractile responses to norepinephrine (NE), the α1-
Fig. 3. Stroke volume after middle cerebral artery occlusion. 
(A,B) Representative images of TTC-stained brain slices of wild-type and
Dll4+/− mice 2 days after MCA occlusion. The infarcted area is demarcated
by the broken blue line. Hemorrhagic areas are present in the infarct zone
in Dll4+/− (B, blue arrow), which are not observed in wild type. Scale bars:
1 mm. (C) Quantification of stroke volume in wild-type and Dll4+/− brains












adrenergic agonist phenylephrine (Phe) and angiotensin II (Ang II)
were significantly larger in Dll4+/− (Fig. 7A,C,D). Importantly, the
maximal contractile response to receptor independent depolarization
using 125 mmol/l K+-Krebs was also significantly larger in Dll4+/−
(Fig. 7A). As arteriolar media thickness (reflecting muscle mass),
was comparable between wild type and Dll4+/− (Fig. 7B), increased
contractile responses to vasopressor stimuli most likely resulted
from changes in smooth muscle excitation-contraction coupling.
The nitric oxide (NO) pathway is activated during the
arteriogenesis process and NO acts as a major vasodilator in
arterioles, enforcing blood flow delivery. Arteriolar relaxation in
response to the NO-dependent vasodilator acetylcholine (Fig. 7E),
as well as the effect of the NO-synthase inhibitor L-NAME
(Fig. 7F), were comparable between Dll4+/− and wild type. In
addition, arteriolar relaxation responses to the NO donor sodium
nitroprusside (SNP) were similar (Fig. 7G). Thus, the NO-
dependent vasorelaxation pathway is functioning adequately in
Dll4+/− mice.
The flow-induced outward remodeling response is essential for
growth and expansion of collateral networks (Eitenmüller et al.,
2006). We exposed arterioles of wild-type and Dll4+/− mice to a
high or low flow regime, for a period of 1 week, and measured the
structural lumen adaptation using the arteriograph (Fig. 8A). We
observed that the flow-induced outward remodeling response was
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severely blunted in Dll4+/− when compared with wild type (Fig. 8B-
D). In wild-type arterioles exposure to a high flow increased lumen
size by about 30%, whereas in Dll4+/− this response was less than
5% (P<0.05) (Fig. 8D). Low flow-induced inward remodeling
responses were comparable in both groups (Fig. 8B-D). Taken
together, Dll4+/− arterioles, when challenged by increased blood
flow, will hardly enlarge, thus predicting impaired expansion of
collateral networks upon FAO. Collectively, Dll4+/− arterioles show
impaired responses to shear stress and to vasoactive molecules that
negatively affect blood flow conductance; this lack of response
renders the arteriolar network susceptible to rarefaction.
DISCUSSION
Formation of extensive collateral networks plays a life-saving role
in ischemic cardiovascular diseases (Meier et al., 2007). Although
stimulation of collateral growth and arteriogenesis has emerged as
one of the principle revascularization approaches, factors
responsible for the presence and expansion of collateral networks
are poorly understood. A recent report (Lucitti et al., 2012) indicates
that VEGF-mediated sprouting events during crucial stages of
embryo development can contribute to collateral formation in the
pial circulation. VEGF acts upstream of Dll4-Notch signaling, and
here we show that Dll4-Notch signaling acts a genetic determinant
of native arterial collateral number. In the mouse brain, native
Fig. 4. Dll4+/− mice show reduced functional recovery after femoral artery occlusion. (A) Representative laser Doppler flow (LDF) images before
and at various time points after femoral artery occlusion (FAO). (B) LDF perfusion shown as ratio of right to left hindlimb (R/L ratio) in wild type (n=20)
and Dll4+/− (n=6). There is reduced perfusion recovery in Dll4+/−. (C) Ischemia score after FAO shows increased ischemia in Dll4+/−. (D,E) Quantitative
analyses of capillary density (D) and capillary-to-fiber ratio (E) on sections of the gastrocnemius muscle. (F,G) Assessment of vascular leakage using
Evans blue dye in wild-type and Dll4+/− adductor muscle (F) and gastrocnemius muscle (G) at 7 days after FAO. Pre, pre-ligation; post, immediately after












arteriolar collateral networks appear as distal end-to-end arteriolar
anastomoses and are detectable at time of birth (Chalothorn and
Faber, 2010). We show that the extent of such native collateral
networks inversely relates to Dll4 gene dosage, with a high number
of collaterals in Dll4 loss-of-function mice, and low collateral
number in Dll4 gain-of-function mice. The effect of Dll4 on native
collateral formation is Notch dependent, as both inhibition of Notch
signaling with DAPT and endothelial-specific deletion of Notch1
phenocopy the Dll4 loss-of-function phenotype. We show that, in
the brain, increased collateral number in Dll4+/− mice results from
hyperbranching of the most distal parts of the embryonic middle
cerebral arteriolar tree, leading to increased end-to-end anastomosis
formation with likewise increased ACA branches. Although
positioning of the main MCA trunk and formation of second order
side branches is not altered in Dll4- or Notch-deficient mice, arterial
formation is slightly delayed; from E13.5 onwards, Dll4+/− and
Notch-deficient mice display a significant increase in distal MCA
arteriolar branches when compared with age-matched wild-type
littermates. Thus, loss of Notch-Dll4 signaling enhances distal
arterial branching morphogenesis, culminating in more native
collaterals in the neonatal pial circulation.
To our surprise, functional recovery and ischemic outcome in
stroke and hindlimb ischemia models were not improved in Dll4+/−
mice, despite the clear increase in collateral vessel number. We also
find that transient Notch inhibition using short-term DAPT
treatment during embryonic development can increase collateral
vessel number, but also in this setting no functional improvement on
post-ischemic recovery is seen in adult mice. The reason for this
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defect is likely to be the defective vessel function. However, it might
be possible to find a developmental time window during which
DAPT treatment will improve collateral vessel number without
adversely affecting vessel function and remodeling. Our data show
that postnatal treatment with DAPT also leads to increased collateral
vessel number; therefore, it might be possible that DAPT treatment
during this time window will have positive effects on post-ischemic
recovery.
These results show that the impact of collateral networks on
functional flow recovery is not solely determined by augmenting
vessel numbers, but rather by vessel functionality. We find increased
vascular proliferation and capillary network formation associated
with plasma leakage in Dll4+/− mice after femoral artery occlusion,
in line with previous reports describing non-productive
angiogenesis in mice after inhibition of Notch using Ad-driven
soluble Dll4, or treatment with Dll4 neutralizing antibodies in the
setting of tumor angiogenesis (Noguera-Troise et al., 2006; Scehnet
et al., 2007; Thurston et al., 2007). Reduced post-ischemic flow
recovery in Dll4+/− mice may therefore be a direct consequence of
the immature dysfunctional capillary bed. However, these effects
occur downstream of the collateral arterial network, which is
increased, not decreased in Dll4+/− mice, and must therefore be due
to alterations in arteriolar architecture and function upstream of the
capillary network.
As Dll4 is required for arterial differentiation, we determined
whether loss of a single Dll4 allele impedes arterial specification in
the hindlimb vasculature. Expression analysis indicates that this is
not the case, and the Notch downstream effector – arterial marker
Fig. 5. Dll4+/− mice show reduced arteriolar
numbers in the ischemic hindlimb. (A) μCT
reconstruction and quantification of arteriolar
number at 16 μm resolution of thigh and calf
portions of wild type and Dll4+/− at 7 days after
FAO. (B,C) Quantitative analysis of μCT images
in the ischemic thigh (B) and the ischemic calf
(C) as total number of vascular structures per
indicated diameter class in consecutive z-axis
slices. (D) Histological analysis of arteriolar
density in wild-type (n=7) and Dll4+/− (n=3)
adductor and gastrocnemius muscle 7 days












Efnb2, is upregulated in Dll4+/− ischemic hindlimb. Recruitment of
collateral networks is triggered by hemodynamic factors, most
notably increases in shear stress (Eitenmüller et al., 2006). Dll4+/−
arterioles show striking abnormalities in vascular remodeling
responses to increases in shear stress; structural outward remodeling
responses in wild type are about sixfold higher than in Dll4+/−. This
means that Dll4+/− arterioles, when exposed to high flow, almost
fail to make a structurally larger lumen. Following Poiseuille’s law,
reduced diameter growth predicts diminished perfusion recovery,
which is indeed in line with the Dll4+/− hindlimb LDF
measurements. Furthermore, a failure to induce a rapid increase in
collateral diameter causes a sustained hypoperfusion of the
downstream areas, and here lack of sufficient blood flow and shear
stress signal is by itself a trigger for vessel pruning. In the mouse
retina IOR model, Dll4-Notch affects blood flow perfusion and
microvessel maintenance by regulating expression of vasoactive
molecules (Lobov et al., 2011). In addition, we find that Dll4 affects
excitation contraction coupling in arterioles, relevant for controlling
vascular tone. The concept that emerges from these observations is
that in developing arterioles Dll4 acts on arterial specification
signaling, whereas in more mature arteries it modulates arteriolar
function. Such a bimodal effect on structure and function may
further fine-tine tissue perfusion and oxygen homeostasis.
Factors regulating arteriolar function downstream of Dll4-Notch
signaling remain to be identified. Previous work has shown that
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Notch signaling positively regulates vascular maturation factors
such as PDGFR-b and TGF-b (Trindade et al., 2008; Williams et
al., 2006), indicating that lack of these factors in Dll4+/− mice may
affect SMC coverage and function. We have indeed observed that
Dll4+/− pial collaterals initially show a delay in SMC coverage, but
this appears to be a transient defect and adult arterial SMC coverage
showed no detectable difference between wild-type and Dll4 mutant
littermates (data not shown). Dll4 blockade has also been shown to
regulate expression of numerous chemokines, which may trigger
crosstalk with inflammatory cells such as monocytes known to be
required for arteriogenesis (Al Haj Zen et al., 2010; Arras et al.,
1998).
Fig. 6. Arterial specification genes are not suppressed in Dll4+/−
mice. (A-F) Quantitative real-time PCR analysis of indicated genes in
gastrocnemius muscle at 7 days after FAO. (A) Expression of hypoxia
inducible factor 1α (Hif1a), (B) hypoxia inducible factor 1β (Hif1b), (C)
vascular endothelial growth factor A (Vegfa), (D) Kdr, (E) Notch1 and (F)
ephrin B2 (Efnb2). n=5 or 6 mice per genotype and data point. Data are
shown as mean±s.e.m. *P<0.05, **P<0.01, ***P<0.001. Fig. 7. Dll4
+/− mice show increased arteriolar contractility.
(A) Contractile force per unit vessel length of mesenteric resistance
arteries examined in a myograph: after challenge with angiotensin II (Ang
II), norepinephrine (NE), phenylephrine (Phe) or direct depolarization
using 125 mmol/l K+ Krebs buffer. Contractility is increased in Dll4+/−. 
(B) Vessel wall media thickness was comparable between wild type and
Dll4+/−. (C,D) Concentration response curves for norepinephrine (NE) and
phenylephrine (Phe). (E) Arterial vasorelaxation in response to increasing
concentration of acetylcholine (ACh). Arteries were pre-constricted with
35 mmol/l K+ Krebs buffer. (F) Arterial vasorelaxation in response to ACh
after pre-treatment with the nitric oxide-synthase inhibitor L-NAME. 
(G) Arterial vasorelaxation in response to increasing concentrations of the
nitric oxide donor sodium-nitroprusside (SNP). Relaxation responses are













In addition to downstream regulators, upstream regulation of Dll4
expression during arteriogenesis also deserves consideration.
Endothelial deletion of Hif2a has recently been shown to lead to a
Dll4-dependent reduction in post-ischemic blood flow recovery,
indicating that Hif2a expression controls arteriogenesis via Dll4-
Notch (Skuli et al., 2012). In addition to Hif2a, inducible blockade
of NFκB in endothelial cells using a transgenic mouse line
overexpressing IκB also leads to reduction in Dll4 levels, retinal
hypervascularization and reduced post-ischemic blood flow
recovery. Activation of Notch signaling via administration of Jag1
peptide rescues a normal vascular phenotype, indicating that NFκkB
signaling, which is controlled by shear stress, regulates arterial
branching morphogenesis via induction of Dll4-Notch signaling
(Tirziu et al., 2012).
Our study may have important implications for future clinical
revascularization approaches. We show that the extent of collateral
network development should be delicately fine-tuned to obtain
optimal flow recovery: the quality is not in numbers. We provide
the proof of concept that it is possible to increase collateral
number pharmacologically by postnatal treatment with a Notch
inhibitor, as postnatal Notch inhibition with DAPT resulted in a
sustained increase in collaterals, similar to the phenotype observed
in adult Dll4+/− mice. Such approaches maybe particularly
important for prevention strategies. In those organs that are
extremely sensitive to short-term hypoxia/ischemia insults, such as
the brain, the therapeutic window is relatively small. Therefore,
increasing the number of collaterals prior to stenosis may alleviate
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or prevent ischemic damage occurring during the early phase upon
stenosis and expand the therapeutic window.
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